John E Pintar Selected Research

John E Pintar Research Topics

Disease

8	Body Weight (Weight, Body) 02/2016 - 06/2007
3	Obesity 08/2016 - 03/2014
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 03/2014
2	Alcoholism (Alcohol Abuse) 10/2019 - 03/2014
2	Neoplasms (Cancer) 01/2019 - 08/2016
2	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2016
1	Pain (Aches) 01/2021
1	Insulin Resistance 01/2020
1	Inflammation (Inflammations) 01/2020
1	Glucose Intolerance 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Binge Drinking 10/2019
1	Opioid-Related Disorders (Opiate Addiction) 06/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Wounds and Injuries (Trauma) 01/2017
1	Hyperphagia (Overeating) 02/2016
1	Binge-Eating Disorder (Binge Eating Disorder) 02/2016
1	Respiratory Insufficiency (Respiratory Failure) 09/2014
1	Mental Disorders (Mental Disorder) 03/2014
1	Infections 12/2010
1	Salmonella Infections (Salmonellosis) 12/2010
1	Prostatic Neoplasms (Prostate Cancer) 02/2009
1	Hypotension (Low Blood Pressure) 09/2008
1	Bradycardia 09/2008
1	Retinal Neovascularization 06/2007
1	Hyperinsulinism (Hyperinsulinemia) 03/2007
1	Lipidoses 11/2006
1	Edema (Dropsy) 11/2005
1	Fever (Fevers) 04/2005
1	Hyperalgesia 05/2004
1	Neuralgia (Stump Neuralgia) 05/2004
1	Chronic Pain 04/2004
1	Catalepsy 11/2002

Drug/Important Bio-Agent (IBA)

4	Opioid Analgesics (Opioids)IBA 01/2017 - 05/2004
4	Morphine (MS Contin)FDA LinkGeneric 01/2017 - 04/2004
4	Peptides (Polypeptides)IBA 10/2013 - 11/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2007
3	NociceptinIBA 10/2019 - 09/2008
3	Analgesics (Analgesic Drugs)IBA 06/2019 - 04/2004
3	Insulin-Like Growth Factor Binding Protein 3IBA 01/2019 - 08/2016
3	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 05/2004
2	Insulin (Novolin)FDA Link 01/2020 - 03/2007
2	Pharmaceutical PreparationsIBA 10/2019 - 03/2014
2	NeuropeptidesIBA 01/2017 - 06/2010
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2017 - 04/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 04/2012 - 06/2007
2	Blood Glucose (Blood Sugar)IBA 06/2010 - 03/2007
1	mitragynineIBA 01/2021
1	AlkaloidsIBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Islet Amyloid PolypeptideIBA 01/2020
1	EnzymesIBA 01/2020
1	Opioid Peptides (Opioid Peptide)IBA 10/2019
1	LigandsIBA 10/2019
1	cis- 1- methyl- 7- ((4- (2,6- dichlorophenyl)piperidin- 1- yl)methyl)- 6,7,8,9- tetrahydro- 5H- benzocyclohepten- 5- olIBA 10/2019
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2017
1	methylnaltrexone FDA Link 01/2017
1	Caspase 3 (Caspase-3)IBA 08/2016
1	Insulin-Like PeptidesIBA 08/2016
1	LY2940094IBA 02/2016
1	Nociceptin ReceptorIBA 02/2016
1	iodobenzoylnaltrexamideIBA 09/2014
1	Antidepressive Agents (Antidepressants)IBA 03/2014
1	Neuropeptide YIBA 10/2013
1	GhrelinIBA 10/2013
1	LeptinIBA 10/2013
1	Insulin-Like Growth Factor Binding ProteinsIBA 04/2012
1	CytokinesIBA 12/2010
1	Narcotic Antagonists (Opioid Antagonists)IBA 04/2010
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2009
1	Oxygen (Dioxygen)IBA 06/2007
1	lysosomal proteinsIBA 11/2006
1	Phenobarbital (Luminal)FDA Link 11/2006
1	LipopolysaccharidesIBA 04/2005
1	Dynorphins (Dynorphin)IBA 05/2004
1	delta Opioid Receptors (delta Opioid Receptor)IBA 04/2004
1	Opiate AlkaloidsIBA 04/2004
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2002

Therapy/Procedure

3	Therapeutics 01/2018 - 04/2004
1	Self Medication 01/2021
1	Caloric Restriction 02/2016
1	Ligation 05/2004